NANorman Arnheim

Norman Arnheim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Norman Arnheim has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Esther P. Leeflang

    Program in Molecular Biology , SHS 172, 835 West 37th Street , University of Southern California , Los Angeles, CA 90089-1340, USA

    2 shared publications
  • Xiang Yao

    Program in Molecular Biology , SHS 172, 835 West 37th Street , University of Southern California , Los Angeles, CA 90089-1340, USA

    2 shared publications
  • Alexandra DÜRr

    INSERM U289 and Fédération de Neurologie, Hôpital de la Salpêtrière , Paris, France

    1 shared publication
  • Alexis Brice

    Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Institut National de la Recherche Médicale-U1127, Centre National de la Recherche Scientifique-UMR7225, APHP, Paris, France

    1 shared publication
  • Andrew B. Buermeyer

    Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland 97201-3098, USA

    1 shared publication
  • Birgit Schechinger

    Department of Animal Science, Agricultural University of Norway, Aas, Norway; 2Department of Genetics, Wroclaw Agricultural University, Wroclaw, Poland; 3Institute of Human Genetics, Karl-Ruprecht University of Heidelberg, Heidelberg, Germany; and 4Molecular Biology Program, University of Southern California, Los Angeles

    1 shared publication

Latest Publications

  • Open Access

    French Machado-Joseph Disease Patients Do Not Exhibit Gametic Segregation Distortion: A Sperm Typing Analysis

    by Raji P. Grewal, Geraldine Cancel, Esther P. Leeflang, Alexandra DÜRr, Mary Sara McPeek, David Draghinas, Xiang Yao, Giovanni Stevanin, Marie-Odile Alnot, Alexis Brice, et al.

    Segregation distortion has been reported to occur in a number of the trinucleotide repeat disorders. On the basis of a sperm typing study performed in patients of Japanese descent with Machado-Joseph disease (MJD), it was reported that disease alleles are preferentially transmitted during meiosis. We performed a sperm typing study of five MJD patients of French descent and analysis of the pooled data shows a ratio of mutant to normal alleles of 379:436 (46.5:53.5%), which does not support meiotic segregation distortion. To confirm these results, sperm typing analysis was also performed using a polymorphic marker, D14S1050, closely linked to the MJD1 gene. Among 910 sperm analyzed, the allele linked to the disease chromosome was detected in 50.3% of the samples and the allele linked to the normal chromosome was found in 49.6% of the sperm. The difference in frequency of these two alleles is not significant (P= 0.8423). Likelihood-based analysis of segregation distortion in the single sperm data using the SPERMSEG program also showed no support for segregation distortion at the gamete level in this patient population. The previous report on the Japanese patients also suggested that disease allele stability may be influenced by a trans effect of an intragenic polymorphism (987 G/C) in the wild-type allele. All of the French patients were heterozygous for this polymorphism. However, analysis of the variance in repeat number in sperm from the French MJD patients overlapped significantly with the variance in repeat number observed in the C/C homozygous Japanese patients.


  • Different mutator phenotypes in Mlh1 - versus Pms2 -deficient mice

    by Xiang Yao, Andrew B. Buermeyer, Latha Narayanan, Doan Tran, Sean M. Baker, Tomas A. Prolla, Peter M. Glazer, R. Michael Liskay, Norman Arnheim

    Deficiencies in DNA mismatch repair (MMR) result in increased mutation rates and cancer risk in both humans and mice. Mouse strains homozygous for knockouts of either the Pms2 or Mlh1 MMR gene develop cancer but exhibit very different tumor spectra; only Mlh1 −/− animals develop intestinal tumors. We carried out a detailed study of the microsatellite mutation spectra in each knockout strain. Five mononucleotide repeat tracts at four different chromosomal locations were studied by using single-molecule PCR or an in vivo forward mutation assay. Three dinucleotide repeat loci also were examined. Surprisingly, the mononucleotide repeat mutation frequency in Mlh1 −/− mice was 2- to 3-fold higher than in Pms2 −/− animals. The higher mutation frequency in Mlh1 −/− mice may be a consequence of some residual DNA repair capacity in the Pms2 −/− animals. Relevant to this idea, we observed that Pms2 −/− mice exhibit almost normal levels of Mlh1p, whereas Mlh1 −/− animals lack both Mlh1p and Pms2p. Comparison between Mlh1 −/− animals and Mlh1 −/− and Pms2 −/− double knockout mice revealed little difference in mutator phenotype, suggesting that Mlh1 nullizygosity is sufficient to inactivate MMR completely. The findings may provide a basis for understanding the greater predisposition to intestinal cancer of Mlh1 −/− mice. Small differences (2- to 3-fold) in mononucleotide repeat mutation rates may have dramatic effects on tumor development, requiring multiple genetic alterations in coding regions. Alternatively, this strain difference in tumor spectra also may be related to the consequences of the absence of Pms2p compared with the absence of both Pms2p and Mlh1p on as yet little understood cellular processes.


  • Open Access

    Analysis of germline mutation spectra at the Huntington's disease locus supports a mitotic [correction of amitotic] mutation mechanism [published erratum appears in Hum Mol Genet 1999 Apr;8(4):717]

    by Esther P. Leeflang, Simon Tavaré, Paul Marjoram, Carolyn O. S. Neal, Jayalakshmi Srinidhi, Heather MacFarlane, Marcy E. MacDonald, James F. Gusella, Margot de Young, Nancy S. Wexler, et al.

    Trinucleotide repeat disease alleles can undergo ‘dynamic’ mutations in which repeat number may change when a gene is transmitted from parent to offspring. By typing >3500 sperm, we determined the size distribution of Huntington's disease (HD) germline mutations produced by 26 individuals from the Venezuelan cohort with CAG/ CTG repeat numbers ranging from 37 to 62. Both the mutation frequency and mean change in allele size increased with increasing somatic repeat number. The mutation frequencies averaged 82% and, for individuals with at least 50 repeats, 98%. The extraordinarily high mutation frequency levels are most consistent with a mutation process that occurs throughout germline mitotic divisions, rather than resulting from a single meiotic event. In several cases, the mean change in repeat number differed significantly among individuals with similar somatic allele sizes. This individual variation could not be attributed to age in a simple way or to ‘cis’ sequences, suggesting the influence of genetic background or other factors. A familial effect is suggested in one family where both the father and son gave highly unusual spectra compared with other individuals matched for age and repeat number. A statistical model based on incomplete processing of Okazaki fragments during DNA replication was found to provide an excellent fit to the data but variation in parameter values among individuals suggests that the molecular mechanism might be more complex.